Micronuclear collapse from oxidative damage.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
30 Aug 2024
Historique:
medline: 31 8 2024
pubmed: 31 8 2024
entrez: 29 8 2024
Statut: ppublish

Résumé

Chromosome-containing micronuclei are a hallmark of aggressive cancers. Micronuclei frequently undergo irreversible collapse, exposing their enclosed chromatin to the cytosol. Micronuclear rupture catalyzes chromosomal rearrangements, epigenetic abnormalities, and inflammation, yet mechanisms safeguarding micronuclear integrity are poorly understood. In this study, we found that mitochondria-derived reactive oxygen species (ROS) disrupt micronuclei by promoting a noncanonical function of charged multivesicular body protein 7 (CHMP7), a scaffolding protein for the membrane repair complex known as endosomal sorting complex required for transport III (ESCRT-III). ROS retained CHMP7 in micronuclei while disrupting its interaction with other ESCRT-III components. ROS-induced cysteine oxidation stimulated CHMP7 oligomerization and binding to the nuclear membrane protein LEMD2, disrupting micronuclear envelopes. Furthermore, this ROS-CHMP7 pathological axis engendered chromosome shattering known to result from micronuclear rupture. It also mediated micronuclear disintegrity under hypoxic conditions, linking tumor hypoxia with downstream processes driving cancer progression.

Identifiants

pubmed: 39208110
doi: 10.1126/science.adj8691
doi:

Substances chimiques

Chromatin 0
Cysteine K848JZ4886
Endosomal Sorting Complexes Required for Transport 0
Membrane Proteins 0
Nuclear Proteins 0
Reactive Oxygen Species 0
CHMP7 protein, human 0
LEMD2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

eadj8691

Auteurs

Melody Di Bona (M)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Yanyang Chen (Y)

Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Albert S Agustinus (AS)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Pharmacology Graduate Program, Weill Cornell Medicine, New York, NY 10065, USA.

Alice Mazzagatti (A)

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Mercedes A Duran (MA)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Matthew Deyell (M)

Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY 10065, USA.

Daniel Bronder (D)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

James Hickling (J)

Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Christy Hong (C)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Lorenzo Scipioni (L)

School of Engineering, University of California, Irvine, CA 92697, USA.
Laboratory for Fluorescence Dynamics, University of California, Irvine, Irvine, CA 92617, USA.

Giulia Tedeschi (G)

School of Engineering, University of California, Irvine, CA 92697, USA.
Laboratory for Fluorescence Dynamics, University of California, Irvine, Irvine, CA 92617, USA.

Sara Martin (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Jun Li (J)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Aušrinė Ruzgaitė (A)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Nadeem Riaz (N)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Parin Shah (P)

Systems Biology Department, Columbia University, New York, NY 10032, USA.

Edridge K D'Souza (EK)

Systems Biology Department, Columbia University, New York, NY 10032, USA.

D Zack Brodtman (DZ)

Systems Biology Department, Columbia University, New York, NY 10032, USA.

Simone Sidoli (S)

Department of Biochemistry, Albert Einstein College of Medicine, New York, NY 10461, USA.

Bill Diplas (B)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Manisha Jalan (M)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Nancy Y Lee (NY)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Alban Ordureau (A)

Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Benjamin Izar (B)

Systems Biology Department, Columbia University, New York, NY 10032, USA.

Ashley M Laughney (AM)

Department of Physiology, Biophysics and Systems Biology, Weill Cornell Medicine, New York, NY 10065, USA.

Simon Powell (S)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Enrico Gratton (E)

School of Engineering, University of California, Irvine, CA 92697, USA.

Stefano Santaguida (S)

Department of Experimental Oncology, European Institute of Oncology IRCCS, 20141 Milan, Italy.
Department of Oncology and Hemato-Oncology, University of Milan, 20122 Milan, Italy.

John Maciejowski (J)

Molecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Peter Ly (P)

Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Thomas M Jeitner (TM)

Department of Radiology, Weill Cornell Medicine, New York, NY 10065, USA.

Samuel F Bakhoum (SF)

Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH